Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease. uri icon

authors

  • Wolfe, Rory
  • Shah, Raj C
  • Ernst, Michael E
  • Lockery, Jessica E
  • Tonkin, Andrew M
  • Abhayaratna, Walter P
  • Gibbs, Peter
  • Wood, Erica M
  • Mahady, Suzanne E
  • Williamson, Jeff D
  • Donnan, Geoffrey A
  • Wetmore, James B
  • Cloud, Geoffrey C
  • Murray, Anne M
  • Polkinghorne, Kevan R
  • Woods, Robyn L
  • McNeil, John J
  • Gallagher, Hugh
  • Roderick, Paul
  • Walker, Rowan
  • Nelson, Mark R
  • Reid, Christopher M

publication date

  • September 10, 2020